Peptides are chains of amino acids linked by peptide bonds. They occur in biology and can also be manufactured for research or medicine. NHGRI's definition describes their chemistry; it does not assign a shared clinical purpose. NHGRI: Peptide definition

The sequence matters because changing the order, length or chemical modification can change a molecule's behavior. Two peptides can belong to the same broad category while interacting with different targets or having very different stability. A naturally occurring sequence is not automatically safe when administered in a manufactured product.

It is useful to separate three levels of discussion. The molecule has a chemical identity. The material has measurable properties such as content, impurities and stability. The finished product has a formulation, manufacturing history and intended use. Evidence at one level does not settle every question at the others.

Some peptides are active ingredients in approved medicines. Others are investigational tools or reagents with limited human data. Approval is a product-specific regulatory conclusion, and FDA cautions against treating general regulatory terminology as proof of approval. FDA: Is it really FDA approved?

Research also progresses through different models. A receptor assay may show binding, a cell experiment may reveal a pathway and an animal model may test a biological hypothesis. Human studies are needed to establish relevant clinical effects, and the design determines how strong a conclusion can be drawn.

This introductory guide offers no list of universally beneficial peptides. The practical habit is to ask four questions whenever a claim appears: which exact molecule, which product, which study and which outcome? Keeping those questions separate makes it easier to understand genuine advances without turning a broad chemical category into a health promise.